Today: 9 June 2026
Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)
14 December 2025
5 mins read

Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica Inc. (NYSE: CLS; TSX: CLS) is ending the week on a sharp down note after a steep tech-led selloff, even as new filings and fresh commentary published Sunday, Dec. 14, 2025 keep the company firmly in the spotlight for investors tracking AI data center infrastructure and hyperscaler spending.

Below is a detailed, publication-ready look at today’s Celestica stock news, forecasts, and analysis, including what moved the shares, what Wall Street is modeling next, and the catalysts that could matter most into early 2026.


Key takeaways for Celestica stock today

  • Shares fell hard Friday amid a broader tech retreat and renewed “AI bubble” chatter tied to mega-cap tech moves. Reuters
  • A cluster of institutional ownership updates published today highlights both new positions and trims—useful context for sentiment after the pullback.
  • Management’s medium-term outlook remains aggressive: Celestica has guided to $16.0B revenue and $8.20 adjusted EPS for 2026, alongside stronger margins and free cash flow.
  • Street targets skew bullish, with notable calls including RBC’s $400 price target and Goldman’s $440 alongside its Conviction List addition.

Celestica stock price action: what happened into Dec. 14, 2025?

Celestica shares saw a sharp risk-off move to close the week:

  • NYSE: CLS last traded around $306.50, down roughly 12.78% versus the prior close, based on the latest available market print.
  • TSX: CLS closed Friday (Dec. 12) at C$421.77, down 12.92% on the day.

In Canada, Reuters highlighted Celestica as a major drag inside a weak tech tape, noting the technology group fell and Celestica ended down about 12.9% on Friday.

Meanwhile, a Sunday write-up noted the stock was down earlier in Friday’s session (before the final close), underscoring how quickly the selloff accelerated.


Why Celestica fell: tech weakness and “AI bubble” worries resurfaced

Friday’s drop wasn’t happening in a vacuum. Reuters attributed the broader risk-off tone to Wall Street declines as Broadcom and Oracle fueled concerns about an AI-fueled bubble, while long-term borrowing costs rose—exactly the kind of macro/valuation narrative that tends to hit high-momentum AI-linked names hardest.

That matters for Celestica because the stock has been widely treated as a picks-and-shovels beneficiary of the AI buildout—especially data center infrastructure ramps. When investors rotate away from expensive growth/AI exposures, “infrastructure enablers” often get sold alongside the chip and cloud leaders.


Today’s (Dec. 14) Celestica news: institutional filings show both buying and trimming

A notable feature of Dec. 14 coverage is a burst of filing-based updates around institutional positioning:

  • Second Line Capital disclosed a new stake of 23,905 shares valued at roughly $3.73M (per the filing summary).
  • Munro Partners reported initiating a stake of 24,855 shares worth about $3.88M.
  • Castleark Management reported trimming its position by 26.3% in Q2, ending with 51,760 shares (about $8.08M in value in the summary).
  • China Universal Asset Management reported cutting its stake by 35.8%, ending with 12,000 shares (about $1.87M in value in the summary).

What this does (and doesn’t) mean:

  • These are not real-time buy/sell signals; they’re disclosures tied to prior-quarter positioning and reporting cycles.
  • But in the wake of a violent down day, they offer a useful reminder that ownership is active—with some funds building exposure even as others reduce it.

Insider activity in focus: a director’s notable buy

Several of the Dec. 14 filing-based updates also referenced insider activity: Director Laurette T. Koellner purchased 6,000 shares at an average price of $341.67 (about $2.05M).

Insider purchases don’t guarantee anything about near-term price action—but in momentum-driven names, they often become part of the narrative investors weigh when deciding whether a sharp pullback is a reset or a warning sign.


The core bull case: Celestica as an AI data center infrastructure lever

Celestica’s own guidance continues to frame the company as a major beneficiary of AI-related buildouts by large customers.

In its Q3 2025 release, Celestica emphasized:

  • Q3 2025 revenue:$3.19B (up 28% year over year)
  • Adjusted EPS:$1.58 (up 52% year over year)
  • Adjusted operating margin:7.6%

And the company went further by laying out a longer runway:

  • 2026 annual outlook:$16.0B revenue and $8.20 adjusted EPS (with management pointing to continued AI data center investment by its largest customers, and indications extending into 2027).

Segment detail adds color to the AI linkage:

  • Connectivity & Cloud Solutions (CCS) segment revenue in Q3: $2.41B, up 43% YoY
  • Hardware Platform Solutions revenue: about $1.4B, up 79% YoY
  • Advanced Technology Solutions (ATS) segment revenue: $0.78B, down 4% YoY

In other words, when investors talk about Celestica as an “AI infrastructure” stock, they’re typically pointing straight at the CCS trajectory and hyperscaler-related programs.


Another Dec. 14 angle: the Google TPU vs. Nvidia Blackwell debate pulls Celestica into the conversation

One of the more “Discover-friendly” pieces published today connected Celestica to the Google TPU ecosystem. A Dec. 14 commentary argued that stocks linked to Google’s TPU orbit—including Celestica (NYSE: CLS)—have outperformed amid renewed debate around AI accelerators, total cost of ownership, and hyperscaler strategies. 24/7 Wall St.

Takeaway for investors: even when Celestica’s day-to-day trading is driven by macro risk sentiment, the strategic debate over which AI compute stacks win can still influence how the market values the company’s long-dated growth.


Wall Street forecasts: price targets, Conviction List support, and what analysts model next

Notable analyst calls in the current cycle

Two widely-circulated calls anchoring the bull narrative:

  • RBC Capital raised its price target to $400 from $315 and reiterated an Outperform rating, citing continued momentum with hyperscalers.
  • Goldman Sachs added Celestica to its U.S. Conviction List, keeping a Buy rating and a $440 price target, based on expected benefits from ongoing hyperscaler/AI spending.

Consensus framing

A Dec. 14 summary also described a consensus backdrop of a “Moderate Buy” profile with an average target around the mid-$300s (as reported in the roundup). MarketBeat

Investors should note the timing: these targets often reflect the optimism embedded after Celestica’s strong 2025 run-up—and sharp down days can compress multiples quickly, even if estimates don’t move immediately.


Earnings outlook: what the next quarter looks like vs. company guidance

From Celestica’s own release:

  • Q4 2025 guidance: revenue $3.325B to $3.575B and adjusted EPS $1.65 to $1.81.

From the broader Street consensus snapshot:

  • Nasdaq’s listed consensus EPS forecast for the Dec. 2025 quarter is about 1.37, with a high estimate around 1.41 (and additional quarterly forecasts shown beyond that).

Why the gap? Company guidance and aggregator consensus can diverge for several reasons (timing, methodology, GAAP vs. non-GAAP alignment, and update frequency). The important practical point is that Celestica itself guided to a materially higher non-GAAP range for Q4 than the consensus figure shown in that snapshot, reinforcing why the stock has been priced as an “earnings momentum” name. GlobeNewswire


Governance watch: board and audit committee transition (recent, still relevant)

Celestica disclosed in an SEC filing that Dr. Luis Müller intends to resign from the board and audit committee chair role effective Jan. 28, 2026, for personal reasons (not due to disagreement), with Amar Maletira set to become Audit Committee Chair at that time.

This isn’t necessarily a price driver on its own—but during volatile periods, investors often pay closer attention to governance headlines, especially when paired with heavy insider and institutional activity.


What to watch next: catalysts into late December and early 2026

Here are the near-term items investors are tracking after the selloff:

  1. Macro data and rates
    Canada’s November CPI release was flagged as a key next datapoint, with expectations referenced in the market wrap.
  2. Earnings timing (late Jan / early Feb window)
    Published calendars vary, but multiple market schedules point to early February 2026 as the expected next report window (often listed as Feb. 4, 2026, subject to company confirmation).
  3. Any revision to AI infrastructure sentiment
    The stock’s sensitivity to AI valuation narratives—explicitly cited in broader market coverage—means Celestica can move sharply on peer read-throughs and hyperscaler capex headlines.

Bottom line: Celestica stock is in a momentum reset—while the 2026 thesis remains intact

As of Dec. 14, 2025, the immediate story in Celestica stock is the collision of two forces:

  • Short-term: a violent pullback driven by broad tech risk-off moves and AI valuation jitters.
  • Medium-term: management’s bullish 2026 outlook (and supportive analyst framing) that still positions Celestica as a key infrastructure beneficiary of hyperscaler AI buildouts.

For investors, the key question now isn’t whether Celestica is “AI-exposed”—it clearly is. The question is whether earnings execution and guidance can keep pace with the expectations embedded in both the stock’s 2025 run and the Street’s higher-end targets.

Stock Market Today

  • Aker BP Share Price Surges Amid Valuation Debate
    June 9, 2026, 11:54 AM EDT. Aker BP (OB:AKRBP) shares climbed to NOK347.7, marking a 55.05% total shareholder return over one year, outperforming peers in Norway's energy sector. Despite this momentum, the stock trades at an 8.6% premium over a fair value of NOK320.11, raising questions about valuation. The company aims to sustain production above 500,000 barrels per day past 2030, backed by projects like Yggdrasil and Johan Sverdrup, supporting revenue growth. Yet, potential risks include higher emissions costs and delays in key developments. Analysts offer cautious pricing, but a discounted cash flow (DCF) model from Simply Wall St suggests a much higher intrinsic value of NOK1,769.75, indicating significant undervaluation. Investors face a valuation divide between conservative targets and optimistic cash flow projections.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next
Previous Story

Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Anthropic Valuation 2025: Claude Maker’s $183B Price Tag Meets $300B+ Funding Talk as IPO Buzz Builds (Updated Dec. 14, 2025)
Next Story

Anthropic Valuation 2025: Claude Maker’s $183B Price Tag Meets $300B+ Funding Talk as IPO Buzz Builds (Updated Dec. 14, 2025)

Go toTop